RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
-12.08%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.42B
AUM Growth
+$2.42B
Cap. Flow
-$174M
Cap. Flow %
-7.21%
Top 10 Hldgs %
25.87%
Holding
146
New
14
Increased
42
Reduced
23
Closed
13

Sector Composition

1 Healthcare 95.03%
2 Consumer Staples 1.05%
3 Consumer Discretionary 0.18%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GRTX
101
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$4.75M 0.2%
500,000
TXG icon
102
10x Genomics
TXG
$1.67B
$4.74M 0.2%
76,000
+3,500
+5% +$218K
NGM
103
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$4.33M 0.18%
351,100
OSW icon
104
OneSpaWorld
OSW
$2.28B
$4.26M 0.18%
1,050,000
+150,000
+17% +$609K
ANAB icon
105
AnaptysBio
ANAB
$609M
$4.24M 0.18%
300,000
+165,000
+122% +$2.33M
IMVT icon
106
Immunovant
IMVT
$2.7B
$3.89M 0.16%
+250,000
New +$3.89M
MYOV
107
DELISTED
Myovant Sciences Ltd.
MYOV
$3.78M 0.16%
500,000
SYRE icon
108
Spyre Therapeutics
SYRE
$1.01B
$3.73M 0.15%
800,000
PHAS
109
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$3.72M 0.15%
1,125,000
PASG icon
110
Passage Bio
PASG
$23M
$3.54M 0.15%
+225,000
New +$3.54M
OBSV
111
DELISTED
ObsEva SA Ordinary Shares
OBSV
$3.37M 0.14%
1,400,000
+610,520
+77% +$1.47M
ADAP
112
Adaptimmune Therapeutics
ADAP
$14.6M
$3.26M 0.14%
1,200,000
+400,000
+50% +$1.09M
AXNX
113
DELISTED
Axonics, Inc. Common Stock
AXNX
$3.18M 0.13%
125,000
-975,000
-89% -$24.8M
TRIL
114
DELISTED
Trillium Therapeutics Inc.
TRIL
$3.03M 0.13%
+750,000
New +$3.03M
GMDA
115
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$3.02M 0.12%
1,000,000
CO
116
DELISTED
Global Cord Blood Corporation
CO
$2.94M 0.12%
925,000
GWPH
117
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.63M 0.11%
+30,000
New +$2.63M
ACRS icon
118
Aclaris Therapeutics
ACRS
$219M
$1.66M 0.07%
1,600,000
XLRN
119
DELISTED
Acceleron Pharma Inc.
XLRN
$1.57M 0.07%
+17,500
New +$1.57M
MGNX icon
120
MacroGenics
MGNX
$119M
$1.34M 0.06%
230,000
FPRX
121
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$908K 0.04%
400,000
BMY.RT
122
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$704K 0.03%
185,150
NBRV
123
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$604K 0.03%
1,050,000
-1,050,000
-50% -$604K
CVET
124
DELISTED
Covetrus, Inc. Common Stock
CVET
$168K 0.01%
20,683
BMY icon
125
Bristol-Myers Squibb
BMY
$96.9B
-150,000
Closed -$9.63M